FRANKFURT (Reuters) - German drugmaker Bayer said its Xarelto blood-thinning pill was recommended for approval by the European drugs regulator for the treatment of dangerous blood clots of the lung, a condition known as pulmonary embolism.

Bayer also won an endorsement from watchdog European Medicines Agency (EMA) for the pill's use in preventing recurrent deep vein thrombosis - another form of blood clotting - Bayer said in a statement on Friday.

EMA's guidance is usually followed by the EU Commission for its decisions on drug approvals.

(Reporting by Ludwig Burger)